Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - iron as ferric hydroxide sucrose compound - parenteral liquid/solution/suspension - iron as ferric hydroxide sucrose compound mineral-iron-base active 20.0 mg/ml - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - anaemia | iron deficiency | iron supplement | anaemia

İsrail - İngilizce - Ministry of Health

csl behring ltd., israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection/infusion - factor viii (human) 250 iu / 5 ml; von willebrand factor 600 iu / 5 ml - coagulation factor viii - coagulation factor viii - congenital and acquired deficiency of blood clotting factor viii: severe or moderate haemophilia, prophylaxis during operation, von willebrand's disease.

Malta - İngilizce - Medicines Authority

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 250 iu von willebrand factor, human 190 iu - antihemorrhagics

Malta - İngilizce - Medicines Authority

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 500 iu von willebrand factor, human 375 iu - antihemorrhagics

Malta - İngilizce - Medicines Authority

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 1000 iu von willebrand factor, human 750 iu - antihemorrhagics

Malta - İngilizce - Medicines Authority

bio products laboratory limited - factor viii, human; von willebrand factor, human - powder and solvent for solution for injection - factor viii, human 250 iu; von willebrand factor, human 430 iu - antihemorrhagics

Malta - İngilizce - Medicines Authority

bio products laboratory limited - factor viii, human; von willebrand factor, human - powder and solvent for solution for injection - factor viii, human 500 iu; von willebrand factor, human 860 iu - antihemorrhagics

Malta - İngilizce - Medicines Authority

bio products laboratory limited - factor viii, human; von willebrand factor, human - powder and solvent for solution for injection - factor viii, human 1000 iu; von willebrand factor, human 1720 iu - antihemorrhagics

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - thymus vulgaris, quantity: 83.25 mg (equivalent: thymus vulgaris, qty 333 mg); selenomethionine, quantity: 30 microgram (equivalent: selenium, qty 12 microgram); zinc gluconate, quantity: 8.36 mg (equivalent: zinc, qty 1.2 mg); astragalus membranaceus, quantity: 300 mg (equivalent: astragalus membranaceus, qty 3 g); ganoderma lucidum, quantity: 50 mg (equivalent: ganoderma lucidum, qty 1 g); verbascum thapsus, quantity: 166.67 mg (equivalent: verbascum thapsus, qty 666.68 mg); d-alpha-tocopheryl acid succinate, quantity: 1.7 mg; calcium ascorbate dihydrate, quantity: 9.68 mg (equivalent: ascorbic acid, qty 8 mg); retinol palmitate, quantity: 64.12 microgram (equivalent: vitamin a, qty 35 re/microgram) - tablet, film coated - excipient ingredients: magnesium stearate; dl-alpha-tocopheryl acetate; silicon dioxide; calcium hydrogen phosphate dihydrate; povidone; croscarmellose sodium; colloidal anhydrous silica; acacia; butylated hydroxytoluene; sucrose; starch sodium octenyl succinate; maltodextrin; carnauba wax; crospovidone; hypromellose; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support immune system health ; maintain/support healthy immune system function ; traditionally used in western herbal medicine to expectorant/clear respiratory tract mucous

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

geistlich pharma australia pty ltd - 58709 - collagen dental regeneration membrane - the devices porous surface facing the bone allows for the ingrowth of bone-forming cells. the dense surface facing the soft tissue prevents the ingrowth of fibrous tissue into the defect. the fibrous microstructure is hydrophilic and readily absorbs fluid and retains its structural integrity when wet. in vivo degradation of the membrane takes several months depending on the surgical site, vascularization and patient comorbidities. the membrane is not radio-opaque. geistlich bio-gide shape is intended to be used in the treatment of hard and soft tissue defects in oral and maxillofacial surgery. the concerned hard and soft tissue defects may be surgically created or result from traumatic injuries, pathological conditions, medical treatments and therapies, or history of personal lifestyle habits. geistlich bio-gide shape is designed to be used for the treatment of alveolar bone defects in extraction sockets. geistlich bio-gide shape can also be used in the surgical treatment of the following clinical conditions: tissue deficiencies in the alveolar ridge; dentofacial anomalies and malformations.